Search

everythinglearnresearchcommunity

for

Search:↓

The hair serum reduced hair loss and improved hair quality in women.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Low iron and L-lysine levels can cause hair loss in women, and increasing these nutrients can reduce hair shedding.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Acne is an important sign of androgen excess disorders in women.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

PCOS involves high 11-oxygenated androgens and BPA may worsen it, while IH is not inflammatory.

Two new reliable Arabic questionnaires for measuring quality of life in women with PCOS were created, one for married and one for unmarried women.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Thorough evaluation and surgery are crucial for managing rare ovarian tumors in postmenopausal women with high androgen levels.

Reducing iron levels didn't improve heart health or metabolism in women with certain ovarian issues.

Gingivitis may increase a hormone linked to ovarian function in women with a certain ovary condition, and treating gum disease could help manage it.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

Finasteride and intense pulsed light effectively reduce unwanted facial hair in women, but may not be cost-effective.

A genetic variant in the androgen receptor gene increases heart disease risk in women but not in men.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Balding men had lower bone density, while balding women had higher hip bone density.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Low-dose oral minoxidil is effective and generally safe for treating hair loss in women.

FPHL affects hair density and diameter, causing visible hair loss in older women.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.